BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2191430)

  • 1. Laboratory diagnosis of antithrombin and heparin cofactor II deficiency.
    Tollefsen DM
    Semin Thromb Hemost; 1990 Apr; 16(2):162-8. PubMed ID: 2191430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory determination of heparin cofactor II.
    Ezenagu LC; Brandt JT
    Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndromes of hypercoagulability and thrombosis: a review.
    Bick RL; Pegram M
    Semin Thromb Hemost; 1994; 20(1):109-32. PubMed ID: 8059229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
    Tran TH; Zbinden B; Lämmle B; Duckert F
    Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombin III and heparin cofactor II].
    Kondo S; Niwa M
    Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.
    Borg JY; Owen MC; Soria C; Soria J; Caen J; Carrell RW
    J Clin Invest; 1988 Apr; 81(4):1292-6. PubMed ID: 3350974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
    Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
    Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary heparin cofactor II deficiency and thrombosis: report of six patients belonging to two separate kindreds.
    Simioni P; Lazzaro AR; Coser E; Salmistraro G; Girolami A
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):351-6. PubMed ID: 2133211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P; Moulonguet-Doleris L; Costa JM; Aiach M
    Thromb Haemost; 1991 Jan; 65(1):20-4. PubMed ID: 2024235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin cofactor II and thrombophilic conditions].
    Hudecek J; Hal'áková E; Ivanková J; Kubisz P
    Vnitr Lek; 1997 May; 43(5):317-9. PubMed ID: 9601856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin Oslo: type Ib classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants.
    Hultin MB; McKay J; Abildgaard U
    Thromb Haemost; 1988 Jun; 59(3):468-73. PubMed ID: 3055413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Juvenile cerebral infarction associated with heparin cofactor II abnormality. A case report].
    Hamasaki S; Motomura M; Nakane S; Nishiura Y; Kondo S
    Rinsho Shinkeigaku; 2000 Apr; 40(4):402-4. PubMed ID: 10967662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin cofactor II deficiency.
    Tollefsen DM
    Arch Pathol Lab Med; 2002 Nov; 126(11):1394-400. PubMed ID: 12421148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.